$PMCB Income Statement

PharmaCyte Biotech, Inc. (PMCB)

Income Statement

Get Income Statement for:

View: Annual Data | Quarterly Data

All numbers in thousands

Period Ending		Jan 31, 2015	Oct 31, 2014	Jul 31, 2014	Apr 30, 2014
Total Revenue		–	–	–	–
Cost of Revenue		–	–	–	–

Gross Profit		–	–	–	–

	Operating Expenses
	Research Development	274	348	–	–
	Selling General and Administrative	946	5,544	1,322	15,202
	Non Recurring	236	353	261	1,247
	Others	–	–	–	–

	Total Operating Expenses	–	–	–	–


Operating Income or Loss		(1,457)	(6,245)	(1,583)	(16,449)

	Income from Continuing Operations
	Total Other Income/Expenses Net	0	2,184	1	(19)
	Earnings Before Interest And Taxes	(1,457)	(4,062)	(1,582)	(12,474)
	Interest Expense	2	2	3	3
	Income Before Tax	(1,458)	(4,064)	(1,585)	(12,478)
	Income Tax Expense	–	–	–	–
	Minority Interest	–	–	–	–

	Net Income From Continuing Ops	(1,458)	(4,064)	(1,585)	(16,471)

	Non-recurring Events
	Discontinued Operations	–	–	–	–
	Extraordinary Items	–	–	–	–
	Effect Of Accounting Changes	–	–	–	–
	Other Items	–	–	–	–


Net Income		(1,458)	(4,064)	(1,585)	(16,471)
Preferred Stock And Other Adjustments		–	–	–	–

Net Income Applicable To Common Shares		(1,458)	(4,064)	(1,585)	(16,471)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com